Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
179 JPY | 0.00% | 0.00% | -5.79% |
2023 | NANO MRNA, Kao Tie Up to Develop mRNA Therapies for Allergic Diseases | MT |
2023 | NANO MRNA Co., Ltd. and Kao Corporation Agree a Comprehensive Collaborative Research for mRNA Drug Discovery | CI |
Sales * | - | Sales 1 * | - | Capitalization | 16.83B 110M |
---|---|---|---|---|---|
Net income * | - | Net income 1 * | - | EV / Sales * | - |
Net cash position * | - 0 | Net cash position 1 * | - 0 | EV / Sales 1 * | - |
P/E ratio * |
-
| P/E ratio 1 * |
-
| Employees | 17 |
Yield * |
-
| Yield 1 * |
-
| Free-Float | 93.47% |
Current month | -3.24% | ||
1 month | -1.65% | ||
3 months | -4.79% | ||
6 months | +1.70% | ||
Current year | -5.79% |
Managers | Title | Age | Since |
---|---|---|---|
Shiro Akinaga
CEO | Chief Executive Officer | 67 | 20-05-31 |
Koji Fujimoto
DFI | Director of Finance/CFO | 51 | 02-10-31 |
Comptroller/Controller/Auditor | 61 | 14-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Satoru Iino
BRD | Director/Board Member | 58 | 12-02-29 |
Kazunori Kataoka
FOU | Founder | 73 | 96-06-13 |
Teruo Okano
FOU | Founder | 75 | 96-06-13 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 179 | 0.00% | 185 000 |
24-05-01 | 179 | -1.10% | 429,200 |
24-04-30 | 181 | +2.84% | 160,000 |
24-04-26 | 176 | -0.56% | 120,700 |
24-04-25 | 177 | -0.56% | 253,300 |
Delayed Quote Japan Exchange, May 02, 2024 at 02:00 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-5.79% | 79.94M | |
-1.46% | 104B | |
+6.71% | 97.47B | |
+5.71% | 22.25B | |
-12.58% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.28% | 16.36B | |
+7.48% | 14.39B | |
+37.53% | 12.37B |
- Stock Market
- Equities
- 4571 Stock